Marcus W. Elrod

Marcus W. Elrod appears in our data through filings on Avadel Pharmaceuticals PLC shares, published by SEC (Form 4). Between 14 December 2016 and 3 January 2017, the trades on record add up to 5 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 13 January 2017: a share grant, in Avadel Pharmaceuticals PLC. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.